Follow
Alessandro Mantovani
Alessandro Mantovani
Division of Endocrinology, Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria
Verified email at univr.it
Title
Cited by
Cited by
Year
Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?
A Lonardo, F Nascimbeni, A Mantovani, G Targher
Journal of hepatology 68 (2), 335-352, 2018
6312018
Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis
A Mantovani, CD Byrne, E Bonora, G Targher
Diabetes care 41 (2), 372-382, 2018
5322018
Complications, morbidity and mortality of nonalcoholic fatty liver disease
A Mantovani, E Scorletti, A Mosca, A Alisi, CD Byrne, G Targher
Metabolism 111, 154170, 2020
3792020
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis
A Mantovani, G Zaza, CD Byrne, A Lonardo, G Zoppini, E Bonora, ...
Metabolism 79, 64-76, 2018
3112018
Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies
A Mantovani, CD Byrne, MH Zheng, G Targher
Nutrition, Metabolism and Cardiovascular Diseases 30 (8), 1236-1248, 2020
3052020
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
A Mantovani, G Petracca, G Beatrice, H Tilg, CD Byrne, G Targher
Gut 70 (5), 962-969, 2021
2772021
Coronavirus disease 2019 (COVID-19) in children and/or adolescents: a meta-analysis
A Mantovani, E Rinaldi, C Zusi, G Beatrice, MD Saccomani, A Dalbeni
Pediatric research 89 (4), 733-737, 2021
2742021
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
A Mantovani, A Csermely, G Petracca, G Beatrice, KE Corey, TG Simon, ...
The lancet Gastroenterology & hepatology 6 (11), 903-913, 2021
2512021
Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
QM Anstee, A Mantovani, H Tilg, G Targher
Nature reviews Gastroenterology & hepatology 15 (7), 425-439, 2018
2452018
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores
G Targher, A Mantovani, CD Byrne, XB Wang, HD Yan, QF Sun, KH Pan, ...
Gut 69 (8), 1545-1547, 2020
2102020
Coronavirus disease 2019 and prevalence of chronic liver disease: A meta‐analysis
A Mantovani, G Beatrice, A Dalbeni
Liver international 40 (6), 1316-1320, 2020
1882020
Patients with diabetes are at higher risk for severe illness from COVID-19
G Targher, A Mantovani, XB Wang, HD Yan, QF Sun, KH Pan, CD Byrne, ...
Diabetes & metabolism 46 (4), 335, 2020
1752020
Glucagon-like peptide-1 receptor agonists for treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: an updated meta-analysis of randomized controlled …
A Mantovani, G Petracca, G Beatrice, A Csermely, A Lonardo, G Targher
Metabolites 11 (2), 73, 2021
1742021
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease
A Mantovani, G Targher
Annals of translational medicine 5 (13), 2017
1662017
Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies
A Mantovani, G Petracca, G Beatrice, A Csermely, H Tilg, CD Byrne, ...
Gut 71 (4), 778-788, 2022
1642022
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis
A Mantovani, G Petracca, G Beatrice, A Csermely, A Lonardo, ...
Gut 71 (1), 156-162, 2022
1642022
Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes
G Targher, A Mantovani, I Pichiri, L Mingolla, V Cavalieri, W Mantovani, ...
Diabetes care 37 (6), 1729-1736, 2014
1572014
Global multi-stakeholder endorsement of the MAFLD definition
N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ...
The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022
1552022
Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes
G Targher, A Mantovani, I Pichiri, R Rigolon, M Dauriz, G Zoppini, ...
Clinical Science 125 (6), 301-310, 2013
1542013
Treatments for NAFLD: state of art
A Mantovani, A Dalbeni
International journal of molecular sciences 22 (5), 2350, 2021
1322021
The system can't perform the operation now. Try again later.
Articles 1–20